Sign in to continue:

Sunday, February 8th, 2026

Announcement of Record Date and Payment Date for Dividend

  • Dividend Details: A proposed first and final tax-exempt (one-tier) dividend of 3 cents per share for the financial year ended 30 June 2024.
  • Record Date: The Share Transfer Books and Register of Members will be closed on 1 November 2024 for the purpose of preparing dividend warrants.
  • Entitlement Cut-off: Duly completed transfers must be received by the Share Registrar by 5:00 p.m. on 30 October 2024 to be eligible for the dividend. Members with securities accounts credited with shares as of 5:00 p.m. on 30 October 2024 will also be entitled to the dividend.
  • Approval Date: The proposed dividend will be approved at the Annual General Meeting scheduled for 22 October 2024.
  • Payment Date: If approved, the dividend will be paid on 15 November 2024.

Special Notes for Investors:

  • Ensure any share transfers are completed by the 30 October 2024 deadline to qualify for the proposed dividend.
  • Monitor the Annual General Meeting outcome on 22 October 2024 for the final approval of the dividend payment.

LHN Limited Announces Cessation of Stabilising Actions After Coliwoo Holdings Spin-Off and SGX Mainboard Listing

LHN Limited Announces Cessation of Stabilising Actions Following Coliwoo Holdings Spin-Off LHN Limited Announces Cessation of Stabilising Actions Following Successful Spin-Off and Listing of Coliwoo Holdings Key Highlights Spin-off and Successful Listing: LHN Limited...

Meta Health Limited EGM 2025: Key Resolutions Passed, Auditor Change, and Constitution Amendments

META HEALTH LIMITED: Detailed Report on Extraordinary General Meeting Outcomes META HEALTH LIMITED: Key Takeaways from the Extraordinary General Meeting (EGM) Held on 3 December 2025 Overview META HEALTH LIMITED convened its Extraordinary General...

iX Biopharma Announces S$5 Million Share Placement to Fund US Expansion and Working Capital Needs 145

iX Biopharma Announces S\$5 Million Share Placement to Fund US Expansion and Strengthen Financials iX Biopharma Unveils S\$5 Million Share Placement: Major Fundraising to Drive US Expansion and Bolster Balance Sheet Key Points Investors...